NASS 2019 Annual Meeting

Kee Kim, MD




Board of Directors: Molecular Matrix (205,000 shares); Consulting: Corentec (B), InVivo Therapeutics (B), Mirus (B), Vertex Pharmaceuticals (B), Zimmer Biomet (A); Grants: Empirical Spine (E, Paid directly to institution/employer), FzioMed (B, Paid directly to institution/employer), InVivo Therapeutics (F, Paid directly to institution/employer), Medtronic (C, Paid directly to institution/employer), Mesoblast (G, Paid directly to institution/employer), Orthofix (F, Paid directly to institution/employer), Pacira Pharmaceuticals (E, Paid directly to institution/employer), Seikagaku (C, Paid directly to institution/employer), Vertex Pharmaceuticals (F, Paid directly to institution/employer), Zimmer Biomet (E, Paid directly to institution/employer); Royalties: Globus (B), Precision Spine (D), Zimmer Biomet (E); Speaking and/or Teaching Arrangements: AOSpine (B).

Sessions :